STX2 and hemolytic-uremic syndrome: The IgG reactivity profile was first analyzed by WB, and a positive immune response to the A and B subunits of Stx2 was observed in six (46.1%) HUS patients and nine (16.6%) healthy individuals (Figure 1A).